Literature DB >> 2143539

Lymphocytic choriomeningitis virus-induced immunodepression: inherent defect of B and T lymphocytes.

M F Saron1, B Shidani, M A Nahori, J C Guillon, P Truffa-Bachi.   

Abstract

Infection of mice with lymphocytic choriomeningitis virus (LCMV) produces a rapidly induced immuno-suppression manifested by low lymphocyte proliferation in response to lipopolysaccharide (LPS) and concanavalin A (ConA). Analysis of the mechanisms underlying the unresponsiveness to these mitogens was undertaken at the cellular and molecular levels 7 days after infection. The selective elimination of CD8+ T cells and the results of coculture experiments demonstrated that unresponsiveness was not due to suppressor cells. Similarly, the role of inhibitory factors such as prostaglandins was excluded, since indomethacin, which inhibits their production, did not reverse the unresponsiveness. Analysis of different cytokines secreted by ConA-activated macrophages or T cells revealed that interleukin-1 (IL-1), synthesized during the T-dependent activation of macrophages by ConA, was normally produced by cells from LCMV-infected mice. In contrast, IL-2, which is produced by activated CD4+ T cells, was undetectable. Addition of exogenous IL-2 did not restore the proliferative response, although the p55-kilodalton protein of the IL-2 receptor was induced by ConA on CD4+ cells from LCMV-infected mice. Our results can be interpreted as showing that (i) unresponsiveness to mitogens of cells from LCMV-infected mice is not due to altered functions of the macrophages with respect to IL-1 production; (ii) CD4+ cells are activated, since the p55 chain of the IL-2 receptor is induced; (iii) the lack of IL-2 production cannot explain T-cell unresponsiveness, since addition of exogenous IL-2 did not restore the proliferative response. Taken together, these data suggest that T-lymphocyte unresponsiveness should be related to an inherent proliferative defect subsequent to T-cell activation and IL-2 receptor expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143539      PMCID: PMC247869     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Control of lymphokine secretion by prostaglandins.

Authors:  D Gordon; M A Bray; J Morley
Journal:  Nature       Date:  1976-07-29       Impact factor: 49.962

2.  Immune responses in vitro. X. Functions of macrophages.

Authors:  C W Pierce; J A Kapp; D D Wood; B Benacerraf
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

3.  Haemopoietic defects in mice infected with lymphocytic choriomeningitis virus. 2. The viral effect upon the function of colony-forming stem cells.

Authors:  K Bro-Jorgensen; M Volkert
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

4.  Lymphocytic choriomeningitis of the mouse. IV. Depression of the allograft reaction.

Authors:  F Lehmann-Grube; I Niemeyer; J Löhler
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

5.  The immunodepressive action of lymphocytic choriomeningitis virus in mice.

Authors:  C A Mims; S Wainwright
Journal:  J Immunol       Date:  1968-10       Impact factor: 5.422

6.  Coexistence of helper and suppressor activities in carrier-primed spleen cells.

Authors:  E L Chan; C Henry
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

7.  Lymphocytic choriomeningitis virus-induced immunosuppression: a virus-induced macrophage defect.

Authors:  R P Jacobs; G A Cole
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

8.  Transient impaired cell-mediated tumor immunity after acute infection with lymphocytic choriomeningitis virus.

Authors:  F Güttler; K Bro-Jorgensen; P N Jorgensen
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

9.  An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus.

Authors:  H Roost; S Charan; R Gobet; E Rüedi; H Hengartner; A Althage; R M Zinkernagel
Journal:  Eur J Immunol       Date:  1988-04       Impact factor: 5.532

10.  Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.

Authors:  J S Goodwin; A D Bankhurst; R P Messner
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  7 in total

1.  Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells.

Authors:  V Bronte; M Wang; W W Overwijk; D R Surman; F Pericle; S A Rosenberg; N P Restifo
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

2.  Lymphocytic choriomeningitis virus-induced immune dysfunction: induction of and recovery from T-cell anergy in acutely infected mice.

Authors:  E A Butz; P J Southern
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

3.  Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression.

Authors:  C C Zarozinski; J M McNally; B L Lohman; K A Daniels; R M Welsh
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency.

Authors:  E S Razvi; R M Welsh
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

5.  Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice.

Authors:  E S Razvi; Z Jiang; B A Woda; R M Welsh
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

6.  Impairment of the cellular immune response in acute murine toxoplasmosis: regulation of interleukin 2 production and macrophage-mediated inhibitory effects.

Authors:  S Haque; I Khan; A Haque; L Kasper
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

7.  Immune response during acute Chandipura viral infection in experimentally infected susceptible mice.

Authors:  Anukumar Balakrishnan; Akhilash Chandra Mishra
Journal:  Virol J       Date:  2008-10-20       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.